abstract |
In the present invention proposed inhibitors of the protein myeloid leukemia cells 1 (Mcl-1), methods for their preparation, associated pharmaceutical compositions and methods of application of the above. For example, the present invention provides compounds of formula I (I) (I) and their pharmaceutically acceptable salts and pharmaceutical compositions containing these compounds. The compounds and compositions of the present invention can be used, for example, in the treatment of diseases or pathological conditions such as cancer. |